GlassScriptPhysician profile
Miguel A Cima
NPI 1053374868
$13,134.59
in general payments reported to CMS, 2019-2025
36 companies · $678 in 2025
The $678 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,968 · 2020: $2,025 · 2021: $1,952 · 2022: $3,477 · 2023: $1,730 · 2024: $304 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,680 · Education: $33.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,679.53 |
| Education | $33.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $2,632.08 | 2019-2023 | Krystexxa |
| Amgen INC. | $1,708.47 | 2019-2025 | Tavneos, Enbrel, Otezla |
| Janssen Biotech, INC. | $1,641.60 | 2019-2025 | Tremfya |
| Mallinckrodt Hospital Products INC. | $1,569.57 | 2020-2023 | Acthar |
| Abbvie INC. | $1,190.00 | 2019-2025 | Rinvoq, Skyrizi |
| Mallinckrodt Enterprises LLC | $521.49 | 2019 | |
| Ucb, INC. | $446.40 | 2019-2024 | Cimzia |
| Novartis Pharmaceuticals Corporation | $385.58 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $346.41 | 2021-2023 | Saphnelo |
| E.R. Squibb & Sons, L.L.C. | $325.80 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $276.79 | 2022-2025 | Purified Cortrophin Gel |
| Mylan Specialty L.P. | $244.94 | 2019-2020 | |
| Celgene Corporation | $209.05 | 2019 | |
| Glaxosmithkline, LLC. | $205.30 | 2019-2021 | |
| Genentech USA, INC. | $183.80 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $154.97 | 2019-2024 | |
| Radius Health, INC. | $129.92 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $128.50 | 2019 | |
| Sunovion Pharmaceuticals INC. | $110.86 | 2019 | |
| Lilly USA, LLC | $109.01 | 2019-2022 | |
| Hikma Pharmaceuticals USA | $79.24 | 2021-2022 | |
| Medexus Pharma, INC. | $70.01 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $60.34 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $57.85 | 2019 | |
| Pacira Therapeutics, INC. | $55.42 | 2019 | |
| Janssen Scientific Affairs, LLC | $53.57 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $36.08 | 2022-2023 | Seglentis |
| Ultragenyx Pharmaceutical INC. | $35.40 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $32.27 | 2019-2023 | Xtampza |
| Allergan, INC. | $31.58 | 2020 | |
| Redhill Biopharma INC. | $20.30 | 2021 | |
| Pfizer INC. | $18.62 | 2019 | |
| Alfasigma USA, INC. | $18.09 | 2021 | |
| Bioventus LLC | $17.59 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.38 | 2019 | |
| Boston Scientific Corporation | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miguel Cima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.